Outcomes of a novel rituximab-based non-myeloablative conditioning regimen for hematopoietic cell transplantation in severe aplastic anemia

[1]  A. Bacigalupo,et al.  Alternative donor transplants for severe aplastic anemia: current experience. , 2016, Seminars in hematology.

[2]  Wenbin Liu,et al.  Efficiency of treatment with rituximab in platelet transfusion refractoriness: a study of 7 cases. , 2015, International journal of clinical and experimental medicine.

[3]  M. MacMillan,et al.  Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation. , 2015, Blood.

[4]  A. Bacigalupo.  Bone marrow transplantation for acquired severe aplastic anemia. , 2014, Hematology/oncology clinics of North America.

[5]  G. Mufti,et al.  Nonmyeloablative peripheral blood haploidentical stem cell transplantation for refractory severe aplastic anemia. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[6]  A. Bacigalupo,et al.  Front-line immunosuppressive treatment of acquired aplastic anemia , 2013, Bone Marrow Transplantation.

[7]  D. Gómez-Almaguer,et al.  Antibodies in the Treatment of Aplastic Anemia , 2012, Archivum Immunologiae et Therapiae Experimentalis.

[8]  S. Kojima,et al.  Aplastic anemia successfully treated with rituximab: the possible role of aplastic anemia‐associated autoantibodies as a marker for response , 2011, European journal of haematology.

[9]  A. Ibatici,et al.  Rituximab treatment for Epstein-Barr virus DNAemia after alternative-donor hematopoietic stem cell transplantation. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[10]  M. Aljurf,et al.  Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors , 2010, Haematologica.

[11]  E. Lanino,et al.  Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA working party , 2010, Haematologica.

[12]  F. Locatelli,et al.  Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party , 2005, Bone Marrow Transplantation.

[13]  Wenbin Liu,et al.  Systemic lupus erythematosis with severe aplastic anemia successfully treated with rituximab and antithymocyte globulin , 1969, Pakistan journal of medical sciences.

[14]  F. Frassoni,et al.  In vivo B-cell depletion with rituximab for alternative donor hemopoietic SCT , 2012, Bone Marrow Transplantation.

[15]  R. Brand,et al.  Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy--The European Group for Blood and Marrow Transplantation experience. , 2000, Seminars in hematology.

[16]  A. Bacigalupo.  Bone marrow transplantation for severe aplastic anemia from HLA identical siblings. , 1999, Haematologica.